Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2005
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572074A2 Stabilized synthetic immunogen delivery system
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1257293B1 Immunomodulatory effective compositions, methods for the production thereof and their use
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer
09/14/2005EP0970081B1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/14/2005EP0833933B1 A vector and method for producing influenza hemagglutinin
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668737A Recombined Bet-V-1 allergen mutants, its preparation method and equipment
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668302A Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/14/2005CN1666996A Fusion protein, gene encoding same, and expression method and use thereof
09/14/2005CN1666992A Medical use of catalpol and its homologs
09/14/2005CN1666773A Pharmaceutical composition for preventing and/or treating oral disease caused by microbe
09/14/2005CN1219057C Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB
09/14/2005CN1218958C Novel cyclosporin with improved activity profile
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218714C Kidney asthenia treating medicine and its prepn process
09/13/2005US6943253 6-phenylpyrrolopyrimidinedione derivatives
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
09/13/2005US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes
09/13/2005US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
09/13/2005US6943195 Cycloalkenone derivative
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943171 For therapy of urological, vascular or pulmonary disorders
09/13/2005US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli
09/13/2005US6942852 N-terminal modifications of RANTES and methods of use
09/13/2005CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2173254C Immunological tolerance-inducing agent
09/09/2005WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082845A1 Novel therapies with somatostatin receptor agonists
09/09/2005WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist
09/09/2005WO2005082407A1 Use of quercetin and resveratrol to treat and prevent oral cancer
09/09/2005WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2556914A1 Amines and amides for the treatment of diseases
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/08/2005US20050197358 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce cytokine biosynthesis or as a viricide or anticarcinogenic agent
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197323 Full or partial glucocorticosteroid replacement therapy for obstructive pulmonary bronchial diseases
09/08/2005US20050197314 Synergistic combination of immunostimulatory CpG oligonucleotides and the immunopotentiating cytokine Flt3 ligand; immunotherapy of tumors, viral infections; cancer vaccines
09/08/2005US20050197288 Administering GH-releasing factor (GRF) and analogs (hexenoyl trans-3)hGRF(1-44)NH2 for altering a lipid parameter
09/08/2005US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/08/2005US20050196471 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
09/08/2005US20050196401 Energy-activated targeted cancer therapy
09/08/2005US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer
09/08/2005DE10393180T5 Uminstallationsweise des Kontrollsystems der antigenetischen Homöostaste des Organismus von Säugetieren (Effekt Kuchartschuk-Radtschenko-Sirman) Uminstallationsweise of the control system of the antigenic Homöostaste the organism of mammals (effect Kuchartschuk-Radchenko-Sirman)
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 1172